Description: Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents. The company offers Egoo.Health Platform, an integrated platform with a measuring instrument with disposable capsules and software, where each capsule contains a test for a specific biomarker or virus. Its biomarkers include C-reactive protein home-testing capsule, PHE/Phenylalanine for PKU patients, and Sars-CoV-2/Influenza multiplex for virus/bacteria tests. The company was incorporated in 2019 and is based in Helsingborg, Sweden.
Home Page: www.qlifeholding.com
Redaregatan 48
Helsingborg,
252 36
Sweden
Phone:
45 21 63 35 34
Officers
| Name | Title |
|---|---|
| Mr. Thomas Warthoe | Co-Founder, CEO & Director |
| Mr. Peter Warthoe | Co-Founder & Chief Scientific Officer |
| Mr. Kasper Damgaard Boel Rousoe | Chief Financial Officer |
| Mr. Jakob Broberg Lind | Global Sales Director Clinical |
Exchange: ST
Country: SE
Currency: Swedish krone (kr)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.3216 |
| Price-to-Sales TTM: | 0.537 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 61 |